MAIA Biotechnology, Inc. (MAIA)
1.355
-0.04
(-2.52%)
USD |
NYAM |
Aug 24, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Shareholders Equity (Quarterly) : 20.68M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.68M |
| March 31, 2026 | 27.76M |
| December 31, 2025 | 2.376M |
| September 30, 2025 | 0.0417M |
| June 30, 2025 | 3.877M |
| March 31, 2025 | 4.942M |
| December 31, 2024 | 3.635M |
| September 30, 2024 | 1.619M |
| June 30, 2024 | 3.162M |
| March 31, 2024 | -5.765M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.4775M |
| September 30, 2023 | 2.748M |
| June 30, 2023 | 6.874M |
| March 31, 2023 | 5.083M |
| December 31, 2022 | 8.508M |
| September 30, 2022 | 12.11M |
| June 30, 2022 | 6.662M |
| March 31, 2022 | 9.014M |
| December 31, 2021 | 9.181M |
| September 30, 2021 | 10.55M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| TG Therapeutics, Inc. | 604.08M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.24M |
| Total Liabilities (Quarterly) | 7.565M |
| Current Ratio | 4.512 |